Willingness to pay for a cure of low-risk melanoma patients in Germany

dc.contributor.authorAugustin, Matthias
dc.contributor.authorBlome, Christine
dc.contributor.authorForschner, Andrea
dc.contributor.authorGutzmer, Ralf
dc.contributor.authorHauschild, Axel
dc.contributor.authorHeinzerling, Lucie
dc.contributor.authorLivingstone, Elisabeth
dc.contributor.authorLoquai, Carmen
dc.contributor.authorSchadendorf, Dirk
dc.contributor.authorUtikal, Jochen
dc.contributor.authorWagner, Tobias
dc.contributor.authorWilden, Sophia
dc.contributor.authorKähler, Katharina C.
dc.date.accessioned2018-06-13
dc.date.available2018-06-13
dc.date.created2018
dc.date.issued2018-06-13
dc.description.abstractMalignant melanoma is potentially life-threatening but in most cases curable if detected early. Willingness to pay (WTP) is a preference-based construct that reflects burden of disease by assessment of the monetary value for a hypothetical cure from disease. Since WTP (directly as total amount of money) has not been assessed so far in patients with low risk melanoma, it was interesting to gain insights in this patient population and then, in a second step, compare it directly with the WTP of their treating dermato-oncologists. WTP was assessed in 125 patients with low-risk melanoma and additionally in 105 treating physicians, asking for the one-time and continuous payments they would be willing to make for a sustainable cure, both as absolute sums and as percentages of monthly income. The median WTP based on one-time payment was €10,000 for patients and €100,000 for physicians; relative numbers were 100% versus 300% of monthly income. For continuous monthly payments, WTP was €500 for patients and €1000 for physicians, relative numbers 25% and 50% of income, respectively. Even after controlling for income differences, there was a significantly higher WTP in physicians for all four questions. Compared to patients with chronic skin diseases such as vitiligo, rosacea, atopic eczema and psoriasis, patients with low-risk melanoma showed a significantly higher WTP. Our data suggest that there is a relevant burden of disease even in patients with low-risk tumors. Higher WTP of physicians underlines the prevalence of differences in disease perception.en
dc.identifier.citationPLoS ONE 13.5 (2018). <http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0197780>
dc.identifier.doihttps://doi.org/10.1371/journal.pone.0197780
dc.identifier.opus-id9780
dc.identifier.urihttps://open.fau.de/handle/openfau/9780
dc.identifier.urnurn:nbn:de:bvb:29-opus4-97804
dc.language.isoen
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/deed.de
dc.subjectPhysicians
dc.subjectHealth economics
dc.subjectMelanomas
dc.subjectCancer treatment
dc.subjectCancer detection and diagnosis
dc.subjectEducational attainment
dc.subjectPublic and occupational health
dc.subjectFinance
dc.subject.ddcDDC Classification::6 Technik, Medizin, angewandte Wissenschaften :: 61 Medizin und Gesundheit :: 610 Medizin und Gesundheit
dc.titleWillingness to pay for a cure of low-risk melanoma patients in Germanyen
dc.typearticle
dcterms.publisherFriedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
local.journal.issue5
local.journal.titlePLoS ONE
local.journal.volume13
local.sendToDnbfree*
local.subject.fakultaetMedizinische Fakultät
local.subject.gnd-
local.subject.sammlungUniversität Erlangen-Nürnberg / Open Access Artikel ohne Förderung / Open Access Artikel ohne Förderung 2018
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
9780_Augustin_willingness.pdf
Size:
548.72 KB
Format:
Adobe Portable Document Format
Description: